InnoCon Medical announces CE marking for the UCon System with Patch Electrode. UCon is now approved in EU countries for dorsal genital nerve stimulation with the Patch Electrode to treat patients with symptoms of overactive bladder (OAB) or bowel dysfunction/fecal incontinence.

The Patch Electrode is non-invasive, highly flexible, and its unique combination of materials provides comfortable adherence to the irregular surfaces of the genitals at the exact location of the Dorsal Genital Nerve. It is designed to stay firmly in place while being comfortable during daily activities. It can be applied and removed within seconds, and replaced as needed to maintain hygiene.

This marks an important regulatory milestone for InnoCon Medical and a proud step in the development of the UCon System. With UCon, we aim to improve patient access to neuromodulation therapy for symptoms of overactive bladder and bowel dysfunction. By making therapy more accessible, we hope to support symptom management for as many patients as possible and help them regain control, confidence, and quality of life.

We thank everyone who has contributed to this achievement and look forward to continuing our work within neuromodulation and pelvic health.